FRFlávia de Paiva Santos Rolim

Flávia de Paiva Santos Rolim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Flávia de Paiva Santos Rolim has a total of 72 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Opsoclonus‐Myoclonus‐Ataxia Revealing Underlying Neuromyelitis Optica Spectrum Disorder

    by Ana Silvia Sobreira Lima Verde, Flávia de Paiva Santos Rolim, Amanda Vale Catunda, José Orlando Ferreira Tomé Filho, Milena Sales Pitombeira, Fernanda Martins Maia Carvalho, Paula Camila Alves de Assis Pereira Matos

  • Open Access

    Ozzy Osbourne and Parkinson's disease: from darkness to awareness

    by Luis F. Fabrini Paleare, José Luiz Pedroso, Flávia de Paiva Santos Rolim, Natália R. Karpejany, Carlos Henrique Ferreira Camargo, Hélio A. G. Teive, Gustavo L. Franklin

    Ozzy Osbourne, the legendary frontman of Black Sabbath, publicly revealed his diagnosis of Parkinson's disease (PD) in 2020, offering visibility to a complex neurodegenerative condition. His case, later linked to a mutation in the PARK2 (parkin) gene, presented atypically with a later age of onset, contributing to ongoing discussions about the phenotypic variability of genetic forms of PD. Beyond medical narratives, Osbourne's openness and philanthropy—culminating in a benefit concert that raised $190 million for Parkinson's and pediatric charities—played a transformative role in destigmatizing the disease. This article explores the scientific and social impact of Osbourne's disclosure, highlighting the role of PARK2 in mitochondrial homeostasis, synaptic integrity, and tumor suppression. We also examine his pursuit of experimental stem cell therapy, discussing its scientific basis, ethical considerations, and current clinical research landscape.

  • Cognitive and psychiatric profile in a Brazilian case of SNCA duplication

    by Flávia de Paiva Santos Rolim, Sylvio Ricard Gonçalves de Souza Lima, Ana Silvia Sobreira Lima Verde, Paulo Sérgio Alves Lisboa, Ingrid César Fernandes, Paula Camila A.A.P. Matos, Verônica Tavares Aragão, André Borges Ferreira Gomes, Norberto Anizio Ferreira Frota, Sarah Teixeira Camargos, et al.

  • Open Access

    Movement Disorders in Neuromyelitis Optica Spectrum Disorder: A Systematic Review

    by Luciana A.F. Bringel, Pedro L.G.S.B. Lima, Pedro V.F. Rodrigues, Francisco L.H.B. Cavalcante, Amanda R. Pinheiro, Fabricia M.S. Saraiva, Cynthia P. Rodrigues, Paulo V.S. Gonçalves, Leonardo J.R.A. Melo, Antônio E. Camelo‐Filho, et al.

    Background: Several movement disorders (MD) have been reported to occur in neuromyelitis optica spectrum disorder (NMOSD). No extensive review has addressed the whole spectrum of MD in NMOSD. Objective: This article aims to review MD in NMOSD, describing its prevalence and features. Methods: A systematic review and prevalence meta‐analysis were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) reporting guidelines. We included articles on NMOSD patients with MD as defined by the 2015 international consensus criteria. Meta‐analysis was considered feasible if the prevalence of certain MDs was evaluated for at least 4 studies with more than 5 patients. Results: Ninety‐six articles were selected from an initial pool of 5441, involving 1751 patients, of whom 487 had MD. The prevalence of anti‐aquaporin‐4 antibodies (AQP4‐IgG) was 79.9% in general and 78.7% in NMOSD‐MD patients. Tonic spasms/paroxysmal dystonia and ataxia were the most prevalent MD in NMOSD, with 39% and 26% prevalence, respectively. Tremor, parkinsonism, myoclonus, chorea, and other hyperkinetic disorders were more rarely reported. Conclusions: A wide range of MDs in NMOSD were found, each with distinct features and frequency in literature. This knowledge might help to identify patients with NMOSD, which presents MD as a clinical feature and improves outcomes.


  • Open Access

    Deep brain stimulation for dystonia: outcomes from a Brazilian cohort

    by Clarice Listik, Eduardo Listik, Flávia de Paiva Santos Rolim, Miriam Carvalho Soares, Renata Montes Garcia Barbosa, Bernardo Assumpção de Monaco, Marina Farah, Marcela Ferreira Cordellini, Tamine Capato, Pedro Renato de Paula Brandão, et al.

    Deep brain stimulation (DBS) is a treatment for dystonia, with most trials conducted in developed countries. Data from developing countries like Brazil are limited. To evaluate the landscape of DBS for dystonia in Brazil, assessing motor outcomes compared with the existing literature. A retrospective multicenter cohort study was conducted via medical record review. Demographics and motor outcomes were collected and analyzed using the Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) from patients across four of Brazil's five macro-regions. The cohort included 60 patients (44.3% female), with DBS primarily targeting the globus pallidus internus (73.3%) or subthalamic nucleus (18.3%). The BFMDRS motor scores decreased from 63.0 ± 26.2 (n = 24) at baseline to 36.7 ± 24.6 at 1-year post-DBS (n = 22, p = 0.0018) and 43.6 ± 35.0 at the last assessment (n = 13, p = 0.0327). The use of DBS yielded significant, sustained motor improvements, consistent with developed countries, highlighting its feasibility and effectiveness in Brazil within diverse healthcare settings.


  • Open Access

    High-intensity focused ultrasound (HIFU) versus deep brain stimulation (DBS) for refractory tremor: team DBS

    by Flávia de Paiva Santos Rolim, Denise Maria Menezes Cury Portela

    Deep brain stimulation (DBS) has been widely accepted as a powerful tool capable of suppressing tremor by modulating the neuronal circuitry, with long-term adaptability and a profile of low adverse effects. It has been the primary treatment for refractory tremor for decades, with sustained long-term efficacy. Recently, magnetic resonance-guided high-frequency focused ultrasound (HIFU) has emerged as an alternative, prompting comparisons between these approaches. Deep brain stimulation offers long-lasting tremor control in Parkinson's disease (PD) and essential tremor (ET). In addition, it enables us to advance our understanding of brain circuits by integrating neuroimaging, electrophysiology, and connectomics data to map the best stimulation spots. Technologies such as adaptive and directional DBS enable real-time adjustments and greater precision, optimizing results and minimizing adverse effects. Although HIFU shows promising results, it remains an ablative and non-adjustable therapy, contrasting with DBS's dynamic and customizable advances.

  • Reinforcement learning-based adaptive deep brain stimulation computational model for the treatment of tremor in Parkinson’s disease

    by Tiezhu Zhao, Bruno Luiz Faustino, Senthil Kumar Jagatheesaperumal, Flávia de Paiva Santos Rolim, Victor Hugo C. de Albuquerque


  • Open Access

    Diagnostic approach in a patient with Creutzfeldt-Jakob disease

    by José Wagner Leonel Tavares-Júnior, Renata de Oliveira Carvalho, Raul Raposo Pereira Feitosa, Flávia de Paiva Santos Rolim, Felipe Araújo Rocha, Milena Sales Pitombeira, George Linard Silva Malveira, João José Freitas de Carvalho, Norberto Anizio Ferreira Frota, Daniel Aguiar Dias

    Prion diseases are an important cause of rapidly progressive dementias. Among them, the most common is sporadic Creutzfeldt-Jakob disease (CJD). It is a rare and incurable disease, with rapid progression to death. Objective: To describe the diagnostic approach of a patient with Creutzfeldt-Jakob disease. Methods: The diagnosis is established through the clinical picture associated with characteristic changes in the brain magnetic resonance imaging, the electroencephalogram, and analysis of specific changes in the cerebrospinal fluid. Results: The present report describes the case of a 53-year-old patient in the city of Fortaleza-CE. The diagnosis was made based on the clinical condition and through diagnostic tests, including 14-3-3 protein and RT QUIC analysis. Differential diagnosis was performed with other rapidly progressive causes, such as infectious and immune-mediated diseases. Conclusions: The diagnosis of probable sporadic CJD was established.